SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: (R)-10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: NC(N(C1=CC=CC=C1C2)C3=CC=CC=C3[C@@H]2O)=O
(R)-Licarbazepine is chemically (R)-10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide. (R)-Licarbazepine is supplied with detailed characterization data compliant with regulatory guideline. (R)-Licarbazepine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Carbamazepine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
An insight into the role of additives in controlling polymorphic outcome: a CO2-antisolvent crystallization process of carbamazepine
Luis Padrela, Jacek Zeglinski, and Kevin M. Ryan
Cryst. Growth Des. 2017, 17, 9, 4544–4553
Nanographitic impurities are responsible for electrocatalytic activity of carbon nanotubes towards oxidation of carbamazepine
Elaine Lay Khim Chng, Martin Pumera
Electrochemistry Communications Volume 13, Issue 8, August 2011, Pages 781-784
Liquid Chromatographic Methods for Assay of Carbamazepine, 10,11-Dihydrocarbamazepine, and Related Compounds in Carbamazepine Drug Substance and Tablets
Terry D Cyr, Fumiko Matsui, Roger W Sears, Norman M Curran, Edward G Lovering
Journal of Association of Official Analytical Chemists, Volume 70, Issue 5, 1 September 1987, Pages 836–840
Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography–tandem mass spectrometry and semi-preparative chromatographic isolation
Saji Thomas a,∗, Chandra S. Mathela b, Ashutosh Agarwal a, Saroj Kumar Paul
Journal of Pharmaceutical and Biomedical Analysis Volume 56, Issue 2, 10 September 2011, Pages 423-428